NEWS

NCODA has uploaded the updated patient survey in both English and Spanish in the member portal. Click here for English version. Click here for Spanish version.

This year’s Spring Summit in Chicago on March 2nd – 4th will cover a variety of topics such as: Sharing Value: NCODA Activities, Tools, Goals, ResourcesDefining EffectivenessAudits – Let’s hear from the auditorsIOD Accounting – Making Sense of the CentsMACRA/MIPS – What it means to you! Sybil GreenThe Problems with SPs and PBMs! War stories […]

As the use of oral oncolytics increases, cancer programs face a number of challenges to ensure high-quality care for cancer patients. There are significant variations in how cancer programs are treating patients with oral oncolytics. Arizona Oncology, a founding member of NCODA, is highlighted within:

Syracuse, NY, October 31, 2016 – NCODA (National Community Oncology Dispensing Association, Inc.) would like to highlight a major victory in the treatment landscape for oncology patients. On Thursday, October 27, CVS Health announced it had reversed its decision to limit Medicare Part D access away from oncology practices with in office dispensing as of […]

MISSION STATEMENT/PHILOPSOPHY: The physicians, staff and management of Utah Cancer Specialists are dedicated to the diagnosis, treatment and management of all forms of cancer and blood related diseases. UCS is dedicated to helping people with these diseases achieve optimum health and quality of life through excellence in the delivery of compassionate medical care. UCS understands […]

Mission Statement: Meeting and exceeding the needs of our patients is our primary goal. We recognize that each patient is an individual with unique needs. Our staff is dedicated to the fight against cancer and providing A New Way of Caring. Locations: Virginia Cancer Specialists has locations in Fairfax, Alexandria, Arlington, Fair Oaks, Gainesville, Loudon, […]

NCODA practices have successfully collaborated with another regional payor for the ability to go beyond the first fill! That brings the number of payers that have now collaborated with NCODA practices up to four! Several NCODA practices are currently in payor discussions!

WASHINGTON — The federal Medicare program and private health insurers waste nearly $3 billion every year buying cancer medicines that are thrown out because many drug makers distribute the drugs only in vials that hold too much for most patients, a group of cancer researchers has found. Click here for the New York Times Article… […]

Oral oncolytic regimens have many benefits; however, patients can encounter barriers (e.g., institutional, socioeconomic, treatment) that can hinder their ability to take their medication as prescribed. Patients with metastatic colorectal cancer (mCRC) face complex dosing schedules that challenge adherence. When patients take oral therapies at home, healthcare professionals (HCPs) can use tools to empower their […]

Approximately 40% of patients treated with anthracyclines are still not receiving National Comprehensive Cancer Network (NCCN) guideline–adherent prophylaxis for chemotherapy-induced vomiting. In most cases, guideline nonadherence was secondary to the lack of a neurokinin 1 (NK1) antagonist. Patients on highly emetogenic chemotherapy should receive prophylaxis in the form of a 5-HT3 antagonist in combination with […]

A REPORT ON CANCER More Than 800 Medicines and Vaccines in Clinical Testing for Cancer Offer New Hope to Patients In recent decades, tremendous – almost previously unthinkable – progress has been made in the fight against cancer. Advances in molecular and genomic research have revealed underlying complexities and provided insights into cancer, which we […]

A Council Bluffs family is furious. Their daughter is battling cancer. She is on a very strict drug maintenance program.When they went to pick up her chemotherapy drugs, they ran into one hurdle after another. "She asked me if she was going to die. That was the hardest," said Makayla Umphreys, Gracie’s mom. Click here […]